SOX9 gene plus heparinized TGF-β 3 coated dexamethasone loaded PLGA microspheres for inducement of chondrogenesis of hMSCs

Biomaterials

Volumn 33, Issue 29, 2012, Pages 7151-7163

  Park, Ji Sun ^a   Yang, Han Na ^a   Woo, Dae Gyun ^a   Jeon, Su Yeon ^a   Park, Keun Hong ^a  

^a CHA University   (South Korea)

Author keywords

Dexamethasone; Heparinized TGF 3; HMSCs; PLGA microspheres; SOX9 genes

Indexed keywords

CELL DELIVERY; CHONDROGENESIS; CONTROL GROUPS; DEXAMETHASONES; EXTRACELLULAR MATRICES; FUNCTIONALIZATIONS; GENE CARRIER; GLYCOSAMINOGLYCANS; GROWTH FACTOR; HMSCS; IN-VITRO; IN-VIVO; LAYER-BY-LAYER METHODS; PLGA MICROSPHERES; POLYMERIC MATRICES; POLYMERIC MICROSPHERE; STEM CELL THERAPY; TYPE II; WOUND TISSUE;

CARTILAGE; CELL CULTURE; COLLAGEN; GENE EXPRESSION; GENE TRANSFER; POLYMERS; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE;

MICROSPHERES;

COLLAGEN TYPE 2; DEXAMETHASONE; GLYCOSAMINOGLYCAN; MICROSPHERE; NANOCOATING; PLASMID DNA; POLYETHYLENEIMINE; POLYGLACTIN; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL GROWTH; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE TARGETING; GENETIC TRANSFECTION; HEPARINIZATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MOUSE; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; SOX9 GENE;

ANIMALS; CELL ADHESION; CELL SURVIVAL; CHONDROCYTES; DEXAMETHASONE; FEMALE; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; LACTIC ACID; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; SOX9 TRANSCRIPTION FACTOR; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84864309430     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.023     Document Type: Article

References (43)

1. Rai B., Lin J.L., Lim Z.X., Guldberg R.E., Hutmacher D.W., Cool S.M. Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds. Biomaterials 2010, 31(31):7960-7970.
2. Martins A., Duarte A.R., Faria S., Marques A.P., Reis R.L., Neves N.M. Osteogenic induction of hBMSCs by electrospun scaffolds with dexamethasone release functionality. Biomaterials 2010, 31(22):5875-5885.
3. Cao N., Cheng D., Zou S., Ai H., Gao J., Shuai X. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials 2011, 32(8):2222-2232.
4. Roessger A., Denk L., Minuth W.W. Potential of stem/progenitor cell cultures within polyester fleeces to regenerate renal tubules. Biomaterials 2009, 30(22):3723-3732.
5. Sachlos E., Auguste D.T. Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation. Biomaterials 2008, 29(34):4471-4480.
6. Rosner M., Siegel N., Fuchs C., Slabina N., Dolznig H., Hengstschläger M. Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat Protoc 2010, 5(6):1081-1095.
7. Masago K., Itaka K., Nishiyama N., Chung U.I., Kataoka K. Gene delivery with biocompatible cationic polymer: pharmacogenomic analysis on cell bioactivity. Biomaterials 2007, 28(34):5169-5175.
8. Lu H., Hoshiba T., Kawazoe N., Chen G. Autologous extracellular matrix scaffolds for tissue engineering. Biomaterials 2011, 32(10):2489-2499.
9. Sapir Y., Kryukov O., Cohen S. Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials 2011, 32(7):1838-1847.
10. Saralidze K., Knetsch M.L., van der Marel C., Koole L.H. Versatile polymer microspheres for injection therapy: aspects of fluoroscopic traceability and biofunctionalization. Biomacromolecules 2010, 11(12):3556-3562.
11. Grafahrend D., Heffels K.H., Beer M.V., Gasteier P., Möller M., Boehm G., et al. Degradable polyester scaffolds with controlled surface chemistry combining minimal protein adsorption with specific bioactivation. Nat Mater 2011, 10(1):67-73.
12. Vlacic-Zischke J., Hamlet S.M., Friis T., Tonetti M.S., Ivanovski S. The influence of surface microroughness and hydrophilicity of titanium on the up-regulation of TGFβ/BMP signalling in osteoblasts. Biomaterial 2011, 32(3):665-671.
13. Mabilleau G., Aguado E., Stancu I.C., Cincu C., Baslé M.F., Chappard D. Effects of FGF-2 release from a hydrogel polymer on bone mass and microarchitecture. Biomaterials 2008, 29(11):1593-1600.
14. Radin S., Chen T., Ducheyne P. The controlled release of drugs from emulsified, sol gel processed silica microspheres. Biomaterials 2009, 30(5):850-858.
15. Kim D.C., Sohn J.I., Zhou D., Duke T.A., Kang D.J. Controlled assembly for well-defined 3D bioarchitecture using two active enzymes. ACS Nano 2010, 4(3):1580-1586.
16. Zhu C., Guo S., Zhai Y., Dong S. Layer-by-layer self-assembly for constructing a graphene/platinum nanoparticle three-dimensional hybrid nanostructure using ionic liquid as a linker. Langmuir 2010, 26(10):7614-7618.
17. Shen H., Hu X., Bei J., Wang S. The immobilization of basic fibroblast growth factor on plasma-treated poly(lactide-co-glycolide). Biomaterials 2008, 29(15):2388-2399.
18. Meng H., Liong M., Xia T., Li Z., Ji Z., Zink J.I., et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010, 4(8):4539-4550.
19. Ahsanulhaq Q., Kim J.H., Hahn Y.B. Immobilization of angiotensin II and bovine serum albumin on strip-patterned ZnO nanorod arrays. J Nanosci Nanotechnol 2010, 10(7):4159-4165.
20. Zhang X.Q., Tang H., Hoshi R., De Laporte L., Qiu H., Xu X., et al. Sustained transgene expression via citric acid-based polyester elastomers. Biomaterials 2009, 30(13):2632-2641.
21. Aina V., Marchis T., Laurenti E., Diana E., Lusvardi G., Malavasi G., et al. Functionalization of sol gel bioactive glasses carrying Au nanoparticles: selective Au affinity for amino and thiol ligand groups. Langmuir 2010, 26(24):18600-18605.
22. Park J.S., Na K., Woo D.G., Yang H.N., Kim J.M., Kim J.H., et al. Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials 2010, 31(1):124-132.
23. Kim J.H., Park J.S., Yang H.N., Woo D.G., Jeon S.Y., Do H.J., et al. The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis. Biomaterials 2011, 32(1):268-278.
24. Wang W., Li B., Li Y., Jiang Y., Ouyang H., Gao C. In vivo restoration of full-thickness cartilage defects by poly(lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes. Biomaterials 2010, 31(23):5953-5965.
25. Gao Y., Chen L., Zhang Z., Chen Y., Li Y. Reversal of multidrug resistance by reductionsensitivelinear cationic click polymer/iMDR1-pDNA complex nanoparticles. Biomaterials 2011, 32(6):1738-1747.
26. Trowe M.O., Shah S., Petry M., Airik R., Schuster-Gossler K., Kist R., et al. Loss of Sox9 in the periotic mesenchyme affects mesenchymal expansion and differentiation, and epithelial morphogenesis during cochlea development in the mouse. Dev Biol 2010, 342(1):51-62.
27. Park J., Zhang J.J., Moro A., Kushida M., Wegner M., Kim P.C. Regulation of Sox9 by Sonic Hedgehog (Shh) is essential for patterning and formation of tracheal cartilage. Dev Dyn 2010, 239(2):514-526.
28. Konishi E., Nakashima Y., Iwasa Y., Nakao R., Yanagisawa A. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum Pathol 2010, 41(2):208-213.
29. Amano K., Hata K., Sugita A., Takigawa Y., Ono K., Wakabayashi M., et al. Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein. Mol Biol Cell 2009, 20(21):4541-4551.
30. Kupcsik L., Stoddart M.J., Li Z., Benneker L.M., Alini M. Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. Tissue Eng Part A 2010, 16(6):1845-1855.
31. Park J.S., Yang H.N., Jeon S.Y., Woo D.G., Na K., Park K.H. Osteogenic differentiation of human mesenchymal stem cells using RGD-modified BMP-2 coated microspheres. Biomaterials 2010, 31:6239-6248.
32. Park J.S., Na K., Woo D.G., Yang H.N., Park K.H. Determination of dual delivery for stem cell differentiation using dexamethasone and TGF-b3 in/on polymeric microspheres. Biomaterials 2009, 30:4796-4805.
33. Na K., Park J.H., Kim S., Sun B.K., Woo D.G., Chung H.M., et al. Delivery of dexamethasone, ascorbate, and growth factor (TGF β-3) in thermo-reversible hydrogel constructs embedded with rabbit chondrocytes. Biomaterials 2006, 27:5951-5957.
34. Park J.S., Yang H.N., Woo D.G., Chung H.M., Park K.H. In vitro and in vivo chondrogenesis of rabbit bone marrow-derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles. Tissue Eng Part A 2009, 8:2163-2175.
35. Ji W., Sun Y., Yang F., van den Beucken J.J., Fan M., Chen Z., et al. Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications. Pharm Res 2011, 28(6):1259-1272.
36. Cushnie E.K., Khan Y.M., Laurencin C.T. Tissue-engineered matrices as functional delivery systems: adsorption and release of bioactive proteins from degradable composite scaffolds. J Biomed Mater Res A 2010, 94(2):568-575.
37. Leipzig N.D., Wylie R.G., Kim H., Shoichet M.S. Differentiation of neural stem cells in three-dimensional growth factor-immobilized chitosan hydrogel scaffolds. Biomaterials 2011, 32(1):57-64.
38. Tsakiridis A., Alexander L.M., Gennet N., Sanchez-Martin R.M., Livigni A., Li M., et al. Microsphere-based tracing and molecular delivery in embryonic stem cells. Biomaterials 2009, 30(29):5853-5861.
39. Braam S.R., Denning C., van den Brink S., Kats P., Hochstenbach R., Passier R., et al. Improved genetic manipulation of human embryonic stem cells. Nat Methods 2008, 5(5):389-392.
40. Babister J.C., Tare R.S., Green D.W., Inglis S., Mann S., Oreffo R.O. Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using "bead-in-bead" polysaccharide capsules. Biomaterials 2008, 29(1):58-65.
41. Jeon S.Y., Park J.S., Yang H.N., Woo D.G., Park K.H. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs. Biomaterials 2012, 33(17):4413-4423.
42. Park J.S., Yang H.N., Woo D.G., Jeon S.Y., Do H.J., Lim H.Y., et al. Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI-modified PLGA nanoparticles. Biomaterials 2011, 32(14):3679-3688.
43. Yang H.N., Park J.S., Woo D.G., Jeon S.Y., Do H.J., Lim H.Y., et al. Chondrogenesis of mesenchymal stem cells and dedifferentiated chondrocytes by transfection with SOX Trio genes. Biomaterials 2011, 32(30):7695-7704.